Centers for Medicare & Medicaid Services’ decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence

Mehdi H. Shishehbor, Christopher J. White, Joshua A. Beckman, Sanjay Misra, Peter A. Schneider, Robert A. Lookstein, Vikram S. Kashyap, Daniel Clair, W. Schuyler Jones, Kenneth Rosenfield, Barry T. Katzen, Michael R. Jaff

Research output: Contribution to journalEditorial

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)558-559
Number of pages2
JournalVascular Medicine (United Kingdom)
Volume23
Issue number6
DOIs
StatePublished - Dec 1 2018

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Shishehbor, M. H., White, C. J., Beckman, J. A., Misra, S., Schneider, P. A., Lookstein, R. A., Kashyap, V. S., Clair, D., Jones, W. S., Rosenfield, K., Katzen, B. T., & Jaff, M. R. (2018). Centers for Medicare & Medicaid Services’ decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence. Vascular Medicine (United Kingdom), 23(6), 558-559. https://doi.org/10.1177/1358863X18802969